Synergistic Embolic Capture Systems for Enhanced Treatment of Blocked Blood Vessels

Publication ID: 24-11857209_0003_PTD
Published: November 07, 2025
Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “Synergistic Embolic Capture Systems for Enhanced Treatment of Blocked Blood Vessels,” Published Technical Disclosure No. 24-11857209_0003_PTD, Published November 07, 2025, available at https://archive.pr1or.art/24-11857209_0003_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,209.

Summary of the Inventive Concept

Integrating AI, IoT, blockchain, and advanced materials with catheter-based emboli removal systems to create more effective, personalized, and secure treatment options for blocked blood vessels.

Background and Problem Solved

The original patent disclosed catheter-based emboli removal devices, but these systems had limitations in terms of real-time detection, secure data storage, and personalized treatment. The new inventive concept addresses these limitations by combining the original device with distinct technologies to create a more powerful system.

Detailed Description of the Inventive Concept

The synergistic embolic capture system comprises a catheter-based emboli removal device, an AI-powered diagnostic module for real-time blood clot detection, an IoT sensor system for monitoring device performance, a blockchain-based secure data storage system for patient treatment information, and advanced materials such as nanomaterial-coated mesh baskets for enhanced emboli capture. The system enables medical professionals to provide personalized treatment recommendations based on AI-powered image analysis, track patient outcomes, and identify trends using a secure data analytics platform.

Novelty and Inventive Step

The new claims introduce novel combinations of AI, IoT, blockchain, and advanced materials with catheter-based emboli removal systems, providing a non-obvious and significant improvement over the original patent. The integration of these distinct technologies enables real-time detection, secure data storage, and personalized treatment, which were not possible with the original device.

Alternative Embodiments and Variations

Alternative embodiments of the synergistic embolic capture system could include variations in the AI-powered diagnostic module, such as using machine learning algorithms for predicting treatment outcomes or incorporating natural language processing for enhanced patient communication. Other variations could involve different advanced materials or IoT sensor configurations to optimize device performance and patient safety.

Potential Commercial Applications and Market

The synergistic embolic capture system has significant commercial potential in the medical device industry, particularly in the treatment of blocked blood vessels, ischemic stroke, deep vein thrombosis, and pulmonary embolism. The system's ability to provide personalized treatment recommendations, track patient outcomes, and ensure secure data storage makes it an attractive solution for healthcare providers and patients alike.

CPC Classifications

SectionClassGroup
A A61 A61B17/22012
A A61 A61B17/221
A A61 A61B2017/22038
A A61 A61B2017/22084

Original Patent Information

Patent NumberUS 11,857,209
TitleDevices and methods for treating blocked blood vessels
Assignee(s)SHANGHAI WALLABY MEDICAL TECHNOLOGIES CO., INC.